Stay updated on Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page
- Check6 days agoChange DetectedAdded revision v3.4.3 to the record history and removed revision v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded site revision v3.4.2 to the history and removed an older funding notice and revision (v3.4.1). These edits affect display metadata rather than the trial record data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check41 days agoChange DetectedAdded a site-wide funding notice and updated the page version to v3.4.1. The previous version v3.4.0 was removed.SummaryDifference0.9%

- Check48 days agoChange DetectedUI changes add a Show glossary option, color-coded highlights for record changes, and a revision tag showing v3.4.0 (with No FEAR Act Data labeling updates). No substantive study content or functionality was altered.SummaryDifference1%

- Check62 days agoChange DetectedRevision history shows a new entry for version v3.3.4 and removal of v3.3.3, indicating an administrative update to the page's history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a Revision: v3.3.3 notice and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 notes from the footer.SummaryDifference0.2%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.